Result
| Trial Name | Status | Phase | Country | City |
|---|---|---|---|---|
| Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma The trial aimed to assess the effectiveness of the combination of the chemotherapy drugs gemcitabine and docetaxel in patients with osteosarcoma that returned (recurrent). In addition to the gemcitabi... |
Completed | Phase 2, | ||
| Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma The main aim of this study was to use changes in MRI measurements to predict tumour response observed at the end of chemotherapy, in patients with osteosarcoma. The trial was terminated because of a l... |
Terminated | Not Applicable, | United States, | Nashville, |
| Observational Study in Localized Osteosarcoma This trial aims to collect information about osteosarcoma that has not spread from its initial location (localised) and different treatments. |
Recruiting | Italy, | Aviano, Candiolo, Trieste, Bari, Bologna, Catania, Firenze, Genova, Milano, Padova, Palermo, Pisa, Roma, | |
| European Study in Bone Sarcoma Patients Over 40 Years This study is a first step of a process to establish the standard chemotherapy treatment for osteosarcoma. It aims to improve outcome for patients with rare tumours such as osteosarcoma. The study aim... |
Completed | Germany, Italy, Sweden, | Stuttgart, Bologna, Lund, | |
| Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults The purpose of the study was to investigate whether functional MRI imaging (diffusion-weighted imaging) is useful for monitoring the treatment response of bone sarcomas in children and young adults. A... |
Unknown status | Belgium, | Leuven, | |
| Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma The trial aims to assess whether dietary behaviour, lifestyle and metabolic interactions will affect patients with Osteosarcoma and Ewing sarcoma. All participants with osteosarcoma or Ewing sarcoma w... |
Recruiting | Italy, | Candiolo, Bologna, Firenze, Milano, Pisa, Roma, Torino, | |
| Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse This trial aims to determine the effectiveness of a drug called metformin at preventing osteosarcoma from coming back (relapse) after finishing treatment. The trial also aims to determine any side eff... |
Recruiting | Phase 2, | Italy, | Bologna, |
| Monitoring Chemotherapy Response of Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical Spectroscopic Imaging This trial aimed to determine the effectiveness of an imaging method called Diffuse Optical Spectroscopic Imaging in monitoring osteosarcoma response to chemotherapy. Being able to monitor how someone... |
Completed | United States, | Irvine, |
-
Trial Name:
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent ChondrosarcomaThe trial aimed to assess the effectiveness of the combination of the chemotherapy drugs gemcitabine and docetaxel in patients with osteosarcoma that returned (recurrent). In addition to the gemcitabi...
Status:
Completed
Phase:
Phase 2,
Country:
City:
-
Trial Name:
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing SarcomaThe main aim of this study was to use changes in MRI measurements to predict tumour response observed at the end of chemotherapy, in patients with osteosarcoma. The trial was terminated because of a l...
Status:
Terminated
Phase:
Not Applicable,
Country:
United States,
City:
Nashville,
-
Trial Name:
Observational Study in Localized OsteosarcomaThis trial aims to collect information about osteosarcoma that has not spread from its initial location (localised) and different treatments.
Status:
Recruiting
Phase:
Country:
Italy,
City:
Aviano, Candiolo, Trieste, Bari, Bologna, Catania, Firenze, Genova, Milano, Padova, Palermo, Pisa, Roma,
-
Trial Name:
European Study in Bone Sarcoma Patients Over 40 YearsThis study is a first step of a process to establish the standard chemotherapy treatment for osteosarcoma. It aims to improve outcome for patients with rare tumours such as osteosarcoma. The study aim...
Status:
Completed
Phase:
Country:
Germany, Italy, Sweden,
City:
Stuttgart, Bologna, Lund,
-
Trial Name:
Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young AdultsThe purpose of the study was to investigate whether functional MRI imaging (diffusion-weighted imaging) is useful for monitoring the treatment response of bone sarcomas in children and young adults. A...
Status:
Unknown status
Phase:
Country:
Belgium,
City:
Leuven,
-
Trial Name:
Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone SarcomaThe trial aims to assess whether dietary behaviour, lifestyle and metabolic interactions will affect patients with Osteosarcoma and Ewing sarcoma. All participants with osteosarcoma or Ewing sarcoma w...
Status:
Recruiting
Phase:
Country:
Italy,
City:
Candiolo, Bologna, Firenze, Milano, Pisa, Roma, Torino,
-
Trial Name:
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of RelapseThis trial aims to determine the effectiveness of a drug called metformin at preventing osteosarcoma from coming back (relapse) after finishing treatment. The trial also aims to determine any side eff...
Status:
Recruiting
Phase:
Phase 2,
Country:
Italy,
City:
Bologna,
-
Trial Name:
Monitoring Chemotherapy Response of Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical Spectroscopic ImagingThis trial aimed to determine the effectiveness of an imaging method called Diffuse Optical Spectroscopic Imaging in monitoring osteosarcoma response to chemotherapy. Being able to monitor how someone...
Status:
Completed
Phase:
Country:
United States,
City:
Irvine,
Disclaimer
- ONTEX is intended to supplement, not replace, your healthcare team. Patients should always discuss a clinical trial with their healthcare team. If a patient is eligible for a trial the trial team will be able to provide more in-depth information about the trial so the patient can make an informed decision before taking part. Trial information has been sourced from www.clinicaltrials.gov. The content is then reviewed weekly by the Osteosarcoma Now team. All the trials also have a patient-friendly summary and key information section written by the team at Osteosarcoma Now. We have also included a description of the medications being used in the trial and summarised the inclusion and exclusion criteria in the ‘who is this trial (not) for’ sections. To the best of our knowledge the clinical trial database is up-to-date and accurate.However, we cannot assume any liability for the accuracy or completeness of the information.